Volume : 10, Issue : 07, July – 2023

Title:

41.FORMULATION AND EVALUATION TRANSDERMAL DELIVERY OFCELECOXIB MICROEMULSION GEL

Authors :

Vishwanadhula Pavani**, Akula Priyanka, Mohammad Ismail, Ampati Srinivas

Celecoxib is an NSAID used to treat inflammatory joint conditions including osteoarthritis. In this study, we set out to create a novel microemulsion formulation for transdermal administration of Celecoxib. To choose excipients with excellent drug loading capacity, solubility of drug in different oils, surfactant, and co-surfactant was assessed in pre formulation tests. Capmul MCM C8 was chosen as the oil in the microemulsion’s formulation, while labrasol and ethanol were chosen as the surfactant and co-surfactant, respectively. The concentrations of the oil phase, Smix, and distilled water used in the preparation of the Celecoxib microemulsion were calculated using pseudo ternary phase diagrams.
Three tests-a centrifugation tests, a heating and cooling cycle test, and a freeze thaw cycle testwere used to determine the optimal formulation. The % transmittance, droplet size, and cloud point of the optimized formulations were also measured.Because of its high % transmittance, the MF2 formulation stands out as the best of the bunch. A minimum globule size of 35.2 nm was observed for MF-2. The zeta potential of MF2 was calculated to be +19.0mV. Compared to previous batches, the MF2 formulation demonstrated faster drug release during the in vitro diffusion test, with peak drug concentrations occurring between 4 and 8 hours after the test began.
Microemulgel was created by adding a gelling agent to the microemulsion at a 1:1.2 ratio (microemulsion: gelling agent). When tested under a wide range of stability circumstances, the microemulgel (PN3) in question performed well. The microemulgel formulation (PN3) loaded with Celecoxib was shown to cause no skin irritation in an in vitro testing. Based on these findings, it seems that a microemulsion formulation of Celecoxib might be an effective formulation for transdermal distribution.
Key Words: Microemulsion, Microemulgel, Celecoxib, Arthritis

Cite This Article:

Please cite this article in press Vishwanadhula Pavani et al, Formulation And Evaluation Transdermal Delivery Ofcelecoxib Microemulsion Gel, Indo Am. J. P. Sci, 2023; 10 (07).

Number of Downloads : 10

References:

.
1. Abrar, B., Anis, S., Tanu, B., & Singh, S. (2012). Formulation and in-vitro evaluation of NSAID’s gel. Int J Curr Pharm Res, 4(3), 56-58.
2. Aundhia, C., Patel, J., Patel, S., Sen, A. K., & Seth, A. (2019). Formulation and Evaluation of Microemulsion Loaded Gel of Celecoxib for Topical Delivery. International Journal of Pharmaceutical Research, 11(2), 1924-1932.
3. Burki, I. K., Khan, M. K., Khan, B. A., Uzair, B., Braga, V. A., & Jamil, Q. A. (2020). Formulation development, characterization, and evaluation of a novel dexibuprofen-capsaicin skin emulgel with improved in vivo anti-inflammatory and analgesic effects. AAPS PharmSciTech, 21(6), 1-14.
4. Chandra, A., Sharma, P. K., &Irchhiaya, R. (2009). Microemulsion-based hydrogel formulation for transdermal delivery of dexamethasone. Asian Journal of Pharmaceutics (AJP): Free full text articles from Asian J Pharm, 3(1), 30-36.
5. Chen, H., Chang, X., Du, D., Li, J., Xu, H., & Yang, X. (2006). Microemulsion-based hydrogel formulation of ibuprofen for topical delivery. International Journal of Pharmaceutics, 315(1-2), 52-58.
6. Cirri, M., Bragagni, M., Mennini, N., & Mura, P. (2012). Development of a new delivery system consisting in “drug–in cyclodextrin–in nanostructured lipid carriers” for ketoprofen topical delivery. European Journal of Pharmaceutics and Biopharmaceutics, 80(1), 46-53.
7. Froelich, A., Osmałek, T., Snela, A., Kunstman, P., Jadach, B., Olejniczak, M., Roszak G. &Białas, W. (2017). Novel microemulsion-based gels for topical delivery of indomethacin: Formulation, physicochemical properties and in vitro drug release studies. Journal of colloid and interface science, 507, 323-336.
8. Ghosh, P. K., & Murthy, R. S. R. (2006). Microemulsions: a potential drug delivery system. Current drug delivery, 3(2), 167-180.
9. Goindi, S., Narula, M., & Kalra, A. (2016). Microemulsion-based topical hydrogels of tenoxicam for treatment of arthritis. AapsPharmscitech, 17(3), 597-606.
10. Guleri, K. T., & Preet, K. L. (2013). Formulation and evaluation of topical gel of aceclofenac. Journal of Drug Delivery & Therapeutics, 3(6), 51-53.
11. Hu, L., Hu, Q., & Yang, J. (2014). Enhancement of transdermal delivery of ibuprofen using microemulsion vehicle. Iranian journal of basic medical sciences, 17(10), 760.
12. Kalpana Madikattuet al, (2016), Microemulsion based Transdermal Gels of Isradipine to Enhance Bioavailability: In vitro and In vivo Evaluation, Asian Journal of Pharmaceutics, (Suppl), 9 (5), S23-S30.
13. Karade, P., Shah, R., Chougule, D., & Bhise, S. (2012). Formulation and evaluation of celecoxib gel. Journal of drug delivery and therapeutics, 2(3), 132-135.
14. Kogan, A., &Garti, N. (2006). Microemulsions as transdermal drug delivery vehicles. Advances in colloid and interface science, 123, 369-385.
15. Kumar, B., Jain, S. K., Prajapati, S. K., Mahor, A., & Kumar, A. (2010). Development and characterization of transdermal microemulsion gel for an antiviral drug. International Journal of Pharmaceutical Sciences and Research, 1(6), 57-74.
16. Kumar, M. S. (2014). Development of Celecoxib Transfersomal gel for the Treatment of Rheumatoid Arthritis. Indian Journal of Pharmaceutical and Biological Research, 2(2), 7-13.
17. Kweon, J. H., Chi, S. C., & Park, E. S. (2004). Transdermal delivery of diclofenac using microemulsions. Archives of pharmacal research, 27(3), 351-356.
18. Lee, J., Lee, Y., Kim, J., Yoon, M., Choi, Y.W., (2005). Formulation of microemulsion Systems for Transdermal Delivery of Aceclofenac. Arch Pharm Res. 28(9), 1097 -1102.
19. Mitra, S. (2013). Arthritis: classification, nature & cause–a review. Am J BiopharmacolBiochem Life Sci, 2(3), 1-25.
20. Naeem, M., Iqbal, T., Nawaz, Z., & Hussain, S. (2021). Preparation, optimization and evaluation of transdermal therapeutic system of celecoxib to treat inflammation for treatment of rheumatoid arthritis. Anais da Academia Brasileira de Ciências, 93.
21. Nitalikar, M. M., &Sakarkar, D. M. (2013). Formulation and evaluation of topical gel of Meloxicam with β-Cyclodextrin complex. Research Journal of Pharmacy and Technology, 6(7), 790-793.
22. Okur, N. U., Yavasoglu, A., &Karasulu, H. Y. (2014). Preparation and evaluation of microemulsion formulations of Celecoxib for dermal delivery. Chemical and pharmaceutical bulletin, 62(2), 135-143.
23. Park, E. S., Cui, Y., Yun, B. J., Ko, I. J., & Chi, S. C. (2005). Transdermal delivery of piroxicam using microemulsions. Archives of pharmacal research, 28(2), 243-248.
24. Patel, J., Patel, B., Banwait, H., Parmar, K., & Patel, M. (2011). Formulation and evaluation of topical aceclofenac gel using different gelling agent. Int J Drug Dev Res, 3(1), 156-64.
25. Ramchandani, U., &Sangameswaran, B. (2013). Formulation and evaluation of topical gel of ketoprofen using different polymers. International Journal of Pharmaceutical & Biological Archive, 4(2), 323-326.
26. Rannou, F., Pelletier, J. P., & Martel-Pelletier, J. (2016). Efficacy and safety of topical NSAIDs in the management of osteoarthritis: evidence from real-life setting trials and surveys. In Seminars in arthritis and rheumatism, 45(4), S18-S21.
27. Ricci, M., Puglia, C., Bonina, F., Di Giovanni, C., Giovagnoli, S., & Rossi, C. (2005). Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC):in vitro and in vivo studies. Journal of pharmaceutical sciences, 94(5), 1149-1159.
28. Salimi, A., Jafarinezhad, S., & Kalantari, A. (2018). Transdermal delivery of ketorolac tromethamine using microemulsion vehicles. Jundishapur J Nat Pharm Prod, 13(4), 1-8.
29. Shah, N. V., Ghelani, T. K., Saini, V., Joshi, U. T., Seth, A. K., Chauhan, S. P., Aundhia C. J. & Maheshwari, R. A. (2011). Development and characterization of microemulsion based system of aceclofenac. Indo Am J Pharm Res, 2(1), 110-124.
30. Sheikh Shafiq. et al, (2007), Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur. J. Pharm. and Biopharm. 66, 227–243.
31. Sheikh, A. A., Ali, S. S., Siddiqui, A. R., Zahir, Z., & Ahmad, A. (2011). Formulation development and characterization of aceclofenac gel containing linseed oil and ginger oleoresin. International Journal of PharmTech Research, 3(3), 1448-53.
32. Shewaiter, M. A., Hammady, T. M., El-Gindy, A., Hammadi, S. H., & Gad, S. (2021). Formulation and characterization of leflunomide/diclofenac sodium microemulsion base-gel for the transdermal treatment of inflammatory joint diseases. Journal of Drug Delivery Science and Technology, 61, 102-110.

</div8